Literature DB >> 15558705

Pediatric nasopharyngeal carcinoma: better prognosis and increased c-Kit expression as compared to adults.

Gil Bar-Sela1, Myriam Weyl Ben Arush, Edmond Sabo, Abraham Kuten, Ira Minkov, Ofer Ben-Izhak.   

Abstract

INTRODUCTION: Nasopharyngeal carcinoma (NPC) in children is distinguishable from the adult form by its close association with Epstein-Barr virus (EBV) infection, a higher rate of undifferentiated histology, and a greater incidence of advanced locoregional disease. PATIENTS AND METHODS: Sixteen NPC patients, < or =20 years of age were identified from our 1976-2001 tumor registry records. Clinical stage, treatment, recurrence, and survival were evaluated. Sections were stained by immunohistochemistry for p53, Bcl-2, Ki67, and c-Kit and by in situ hybridization for EBER. Obtained data were compared to 32 adult patients. All patients had undifferentiated or non-keratinizing NPC.
RESULTS: EBER was positive in 100% of children, compared to 90% of adults. Comparing children to adults, median Ki67 index was 49% and 30%, p53 positive tumors were 69% and 94%, positive Bcl-2 was 63% and 72%, and positive c-Kit was 88% and 28%, respectively.
CONCLUSION: No parameter had significant predictive values for survival, although c-Kit expression had a trend for better prognosis in the pediatric group. By univariate analysis of all 48 cases, positive c-Kit was associated with better survival (P = 0.029), largely due to the better survival of the pediatric group. By multivariate analysis, increased stage (P = 0.006) and older age (P = 0.044) correlated with worse prognosis. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15558705     DOI: 10.1002/pbc.20264

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Changes in c-Kit expression levels during the course of radiation therapy for nasopharyngeal carcinoma.

Authors:  Feng Jiang; Wei Hu; Bicheng Zhang; Jing Xu; Yongjie Shui; Xiaofeng Zhou; Xiaoqiu Ren; Xiaozhong Chen; Li Shen; Qichun Wei
Journal:  Biomed Rep       Date:  2016-09-12

2.  The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients.

Authors:  Ismail Matalka; Mohammad Al Hamad; Maysa Al-Hussaini; Firas Q Alzoubi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-03-16       Impact factor: 2.503

3.  Sinonasal and laryngeal carcinoma in children: correlation of imaging characteristics with clinicopathologic and cytogenetic features.

Authors:  C D Robson; R Rahbar; S O Vargas; K J Marcus; J W Mack; G R Licameli; H E Grier
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-24       Impact factor: 3.825

4.  Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma.

Authors:  Eng-lai Tan; G Selvaratnam; R Kananathan; Choon-kook Sam
Journal:  BMC Cancer       Date:  2006-09-24       Impact factor: 4.430

5.  Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

Authors:  Jian-Wei Zhang; Tao Qin; Shao-Dong Hong; Jing Zhang; Wen-Feng Fang; Yuan-Yuan Zhao; Yun-Peng Yang; Cong Xue; Yan Huang; Hong-Yuan Zhao; Yu-Xiang Ma; Zhi-Huang Hu; Pei-Yu Huang; Li Zhang
Journal:  Chin J Cancer       Date:  2015-04-08

6.  Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

Authors:  Beatriz de Melo Maia; André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Glauco Baiocchi; Flávia Munhoz Cestari; Monica Maria Stiepcich; Ludmila Thomé Domingues Chinen; Kátia C Carvalho; Fernando Augusto Soares; Rafael Malagoli Rocha
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.